7.500.40% ( -0.03 )
Delay Trading: Nov 16, 11:21:48Financials
Q3 2026 Earnings
Financial report interval: 2026.06.30 - 2026.09.30
Overview: Xintian Pharma(002873) the Revenue is 171.67 M (-14.32%);the EBIT is 10.43 M (-34.52%);the EPS is 0.05 (+16.91%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.17B14.32%
----
----
EBIT
0.01B34.52%
----
----
EPS
0.0516.91%
----
----
Upcoming earnings report - FY2026 Annual Earning Release
Available dateMar 31, 2027
Estimate Revenue1.339 B
Estimate EBIT152.31 M
Estimate EPS0.58
Revenue
ActualEstimateUnit: CNY
Quarterly
EBIT
ActualEstimateUnit: CNY
Quarterly
Net income
ActualEstimateUnit: CNY
Quarterly
EPS
ActualEstimateUnit: CNY
Quarterly
